Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,477 total articles
Merck announced a $53 per-share all-cash acquisition of Terns Pharmaceuticals to add TERN-701 to its hematology pipeline. TERN trades at $52.96 — essentially at the offer level — creating a mid-term merger-arbitrage setup. The trade is a buy with a tight horizon toward a Q2 2026 close, but it comes with deal-execution risk after Merck trimmed a pri…
Baker Hughes is cycling through deliberate portfolio simplification, a meaningful order beat and large note issuance that together create a narrow window where closing a divestiture and redeploying cash should re-rate the stock. Enter at $69.90, stop $65.00, target $80.00 over a position trade (45 trading days) to capture accretion and sentiment up…
Nebius (NBIS) is trading just below its recent highs after a string of bullish catalysts — including a $643M Eigen AI acquisition and blowout growth projections. Technicals and volume suggest a near-term breakout; this is a high-risk, high-reward swing trade setup for traders willing to accept volatility and event risk ahead of earnings and integra…
Celestica is squarely in the path of accelerated demand for AI servers and networking gear after a recent Q1 beat and an AMD partnership for rack-scale systems. The company's revenue momentum, raised guidance and manufacturing scale create a compelling trading setup, but a premium multiple and supply-chain execution remain the primary risks. This t…
Trinity Industries (TRN) has moved sharply higher but still trades at a modest P/E and yields ~3.4%. Weak 2025 results pushed consensus estimates down; we think those estimates remain too low and position for upside on improving Rail Products deliveries and steady Leasing cash flow. Enter on a small pullback, size carefully given balance-sheet leve…
Microsoft benefits from an intense AI arms race even if it does not monopolize the model market. Brutal competition increases enterprise cloud demand, fuels infrastructure spending and strengthens Microsoft’s recurring software cash flows. Trade idea: long Microsoft with a clear entry, stop and target over a 180 trading-day horizon.
Popular, Inc. (BPOP) is trading near its 52-week high on a mix of steady fundamentals and improving technicals. With a market cap near $9.7B, P/E of ~11.6, ROE above 13%, and a 2.0% yield, the stock looks like a defensible long for a swing horizon (45 trading days). The trade plan is to buy at $149.35, place a stop at $138.00, and target $170.00, b…
Dolby dropped to the low $50s on heavy volume, creating an opportunity to add a durable licensing business with steady FCF, a 2.4% yield, and optional upside from faster adoption of Atmos and Vision. This trade is for patient investors who can tolerate a mid-single-digit drawdown while waiting up to 180 trading days for a recovery.
Melco reported operational strength and attractive valuation metrics that, together with liquidity and asset-quality wins, support a bullish swing trade. We lay out an entry at $5.50, a stop at $4.90 and a target of $8.50 with a primary horizon of mid term (45 trading days).
American Express (AXP) combines a subscription-like revenue profile from card fees and affluent customer loyalty with improving fundamentals: double-digit revenue growth in Q1, $14.3B in free cash flow, and a sub-20x earnings multiple. We recommend a tactical long with a clear stop and two targets over a mid-term (45 trading days) horizon to captur…
Denali (DNLI) is a platform biotech with a rare, potentially high-value capability: the Enzyme TransportVehicle (ETV) that reliably shuttles biologics across the blood-brain barrier. Recent clinical data for tividenofusp (DNL310) and ongoing readouts across lysosomal storage disorder programs make this a buy-the-platform trade. Entry at $18.30, sto…
James Hardie (JHX) has been punished since the AZEK acquisition and a weak North America print in 08/19/2025. The drop priced in near-term execution risk but left a company with $676M of trailing free cash flow, an enterprise value of roughly $13.8B, and a market cap near $12.0B. For traders willing to accept headline risk, JHX offers a mid-term (4…
Atlanta Braves Holdings (BATRA) pairs a market-leading MLB franchise with a growing mixed-use real estate complex. At $54.14 the stock trades with growth expectations priced in, but multiple revenue levers - ticketing, local media, sponsorships and The Battery Atlanta leasing - plus favorable seasonality and momentum make a long trade attractive. E…
GoDaddy generates roughly $1.58B in free cash flow on a market cap near $11.6B, trading at a price-to-free-cash-flow near 7.3. After a guidance miss and promotional pricing noise in early 2026, the shares look like an income-style cash-flow buy with a clear trade entry, stop and target. This idea treats GDDY more like an annuity with optional upsid…
Roku has hit fresh 52-week highs after a multi-quarter turnaround to profitability and expanding free cash flow. The stock is showing momentum, supported by higher advertising revenue, stronger distribution partnerships and a growing Roku Channel. This trade idea lays out an actionable long trade with entry, stop and target while weighing upside ca…
Chevron's low leverage, $16.6B of free cash flow and 3.6% yield make it a resilient beneficiary of a structurally tighter oil market. Recent supply shocks and elevated crude reshape the earnings baseline; the market has not fully priced a sustained higher-oil equilibrium. This is a position trade: enter at $190.63, stop at $176.00, target $215.00 o…
Nvidia's headline narrative has centered on training GPUs and generative-AI hype. The next meaningful leg of upside is more subtle: massive deployment of inference silicon across cloud pockets, edge endpoints and new network architectures. Backing a long position here captures that rollout while respecting the valuation and competitive risks.
Newmont (NEM) is trading at a reasonable multiple despite record cash generation and aggressive capital returns. Buybacks, low operating costs and a clean balance sheet create asymmetric upside vs. downside that favors a long trade over a 180-trading-day horizon.
Argan posted a Q4 beat and now sits on a $2.9 billion backlog, expanding margins and strong free cash flow. At $702.30 the shares look expensive on headline multiples, but FCF generation, zero reported debt, and accelerating demand for reliable energy infrastructure justify a mid-term, high-conviction long. Enter at $700.00, stop at $625.00, target…
Delek Logistics Partners (DKL) presents an actionable long trade: buy near $53.96, target $61.00, stop $48.50. The combination of an 8%-plus yield, record adjusted EBITDA in 2025, a larger third-party revenue mix, and bullish momentum argue for a re-rating. Key risks include commodity exposure, distribution sustainability, and macro-driven midstrea…
Blue Owl (OWL) is a beaten-down alternative asset manager trading near $10 with a ~9% yield, meaningful free cash flow and technical signs of accumulation. This trade idea outlines a high-conviction long with entry, stop and target, a fundamental case tied to fee stability and asset-liability optionality, catalysts that could re-rate the stock, and…
BWX Technologies (BWXT) is trading below its April highs after a strategic commercial acquisition and a sector pullback. The business is cash-generative, backed by long-dated government work, and benefits from renewed political and commercial support for nuclear power. For traders willing to accept a crowded valuation, a disciplined long into earni…
JD.com trades at a $41.2B market cap with a P/E of 16.9 and a 3.23% yield. Its logistics arm is increasingly monetizable through automation and external customers, while AI and new-business initiatives create earnings optionality. Technicals sit near support and institutional short interest is manageable — a tactical long here targets a re-rating t…
Bristol-Myers Squibb (BMY) is trading near $58.50 with a sizable growth portfolio led by CAR-T and recently stronger-than-expected Q1 results. The market is underappreciating durable revenue growth from Breyanzi and allied biologics, plus a healthy free cash flow stream that supports dividends and reinvestment. We lay out a long trade with a clear …
Upstart's shares are trading near $32.77 with a $3.1B market cap despite improving loan trends and a manageable short interest profile. We see a favorable risk/reward for a mid-term swing: entry $32.75, stop $30.50, target $43.00 (mid term - 45 trading days). The trade assumes an earnings beat and stabilization of Model 22 approval dynamics; litiga…
